RedHill Biopharma (RDHL) EPS (Basic) (2012 - 2023)
RedHill Biopharma's (RDHL) quarterly EPS (Basic) came in at $0.95 in Q2 2023, up 570.0% year-over-year from $0.14 in Q2 2022, and up 844.05% quarter-over-quarter from -$0.13 in Q1 2023.
Powered by 
Analysis
RedHill Biopharma (RDHL) EPS (Basic) (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported EPS (Basic) for 12 consecutive years, with $0.95 the latest figure, recorded in Q2 2023.
- On a quarterly basis, EPS (Basic) rose 570.0% year-over-year to $0.95 in Q2 2023; TTM through Jun 2023 was -$0.65, a 73.28% increase from a year earlier, with the FY2025 full-year figure at -$0.0, up 94.81% from the prior year.
- EPS (Basic) was $0.95 for Q2 2023 at RedHill Biopharma, up from -$0.13 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.95 in Q2 2023 and troughed at -$3.12 in Q4 2021.
- A 5-year average of $0.07 and a median of $0.37 in 2021 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) plunged 853.84% in 2021 and jumped 570.0% in 2023, its largest moves.
- Over 5 years, EPS (Basic) stood at $0.4 in 2019, then climbed by 3.88% to $0.41 in 2020, then sank by 853.84% to -$3.12 in 2021, then jumped by 64.04% to -$1.12 in 2022, then jumped by 184.75% to $0.95 in 2023.
- The last three EPS (Basic) figures came in at $0.95 (Q2 2023), -$0.13 (Q1 2023), and -$1.12 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.81 Bn | 39.16 Bn | 2.15 Bn | -0.49 |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | -0.10 |
| 3 | Dr Reddys Laboratories | 9.90 Bn | 9.73 Bn | 396.53 Mn | 0.06 |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | 0.22 |
| 5 | Bausch Health Companies | 2.32 Bn | 479.50 Mn | 2.10 Bn | 0.69 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -0.23 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.12 Bn | 165.89 Mn | 1.17 |
| 8 | Amphastar Pharmaceuticals | 997.70 Mn | 707.58 Mn | 93.47 Mn | 0.70 |
| 9 | Fennec Pharmaceuticals | 395.89 Mn | 354.64 Mn | 17.15 Mn | 0.06 |
| 10 | RedHill Biopharma | 179.21 Mn | 179.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 0.95 |
| Mar 31, 2023 | -0.13 |
| Dec 31, 2022 | -1.12 |
| Sep 30, 2022 | -0.46 |
| Jun 30, 2022 | 0.14 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | -3.12 |
| Sep 30, 2021 | 0.37 |
| Jun 30, 2021 | 0.57 |
| Mar 31, 2021 | 0.37 |
| Dec 31, 2020 | 0.41 |
| Sep 30, 2020 | 0.35 |
| Jun 30, 2020 | 0.30 |
| Mar 31, 2020 | 0.55 |
| Dec 31, 2019 | 0.40 |
| Sep 30, 2019 | 0.43 |
| Jun 30, 2019 | 0.60 |
| Mar 31, 2019 | 0.37 |
| Dec 31, 2018 | 0.54 |
| Sep 30, 2018 | 0.53 |